X0306 4 2019-01-07 0 0000827871 EAGLE PHARMACEUTICALS, INC. EGRX 0001590862 Meyers Pete A. C/O EAGLE PHARMACEUTICALS, INC. 50 TICE BLVD., SUITE 315 WOODCLIFF LAKE NJ 07677 0 1 0 0 Chief Financial Officer Common Stock 2019-01-07 4 F 0 600 41.33 D 7100 D Common Stock 2019-01-23 4 A 0 19300 A 26400 D Employee Stock Option (right to buy) 42.40 2019-01-23 4 A 0 43200 0.00 A 2029-01-23 Common Stock 43200 43200 D Represents shares withheld to satisfy withholding tax obligations. Represents restricted stock units ("RSUs"). The RSUs vest over a period of four years, with 25% of the RSUs vesting on each of the one, two, three and four-year anniversaries of January 23, 2019, subject to the Reporting Person's continuous service with the Issuer as of the applicable vesting date. Each RSU represents a contingent right to receive one share of the Issuer's common stock. The option vests over a period of four years, with 25% of the shares underlying the option vesting on January 23, 2020, the first anniversary of the date of grant, and the remainder vesting in 36 equal monthly installments thereafter, subject to the Reporting Person's continuous service with the Issuer as of the applicable vesting date. /s/ Scott Tarriff, Attorney-in-Fact 2019-01-25